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ABSTRACT
There are a number of reasons to believe that a '

dedicated outpatient breast MRI center offers a good or
even extraordinary professional business opportunity.

Medical technologies continue to rapidly ’ advance and
market pressures continue to force all segments of

healthcare to simultaneously reduce costs and increase
quality of service. The goal is to develop an imaging
center that is financially stable and provides superior

service and for breast health care.
From the health professional and business

perspective, the factors critical to investing

successfully in this evolving environment includes having
an intimate understanding of medical imaging, an

•

understanding of the impact this type of service is likely
to have in the healthcare marketplace, and a solid

projection of financial stability.

The internal analysis reflects the general lack of
competition in the area of breast MRI services. In

addition, there is considerable potential to provide a
higher level of service in a dedicated center.

The market analysis demonstrates that there is a
sufficient population to make this project feasible,

providing the Center is able to accept all payers.

iii

.

The financial analysis indicates that this project

can generate a positive contribution each year, and can
sustain its operations long term.

Based on these findings, it is recommended to proceed
with a formal business plan that will address build-out
specifics, third-party payer negotiations, and a detailed

marketing plan.
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CHAPTER ONE
INTRODUCTION

Breast cancer is a major health problem for American
women, affecting approximately 1 in 8 American women in

their lifetime, and it accounts for over 40,000 deaths per
year. Over the past few decades, breast cancer awareness,

imaging technology, and access to treatment have improved
significantly.
Advances in breast imaging over the past thirty years

have been great and are delineated by four major eras.
During the first era (1970's - 1984), only screen film
mammography was available. The screen film provided a view

of tissue densities, but was limited in providing
information on sensitivity and specificity of the

densities, with a false-negative rate of about 10% to 25%.

In the second era (1985 - 1995), mammography was

complemented by utilizing higher resolution ultrasound to

differentiate between solid and cystic masses, and

•

characterizing solid masses into the categories benign,
indeterminate, or high suspicion for malignancy. The third

era (late 1999-'s to early 2000s) marked the addition of
computer-aided detection, a software program that aids the
radiologist in focusing on subtle lesions, especially

1

subtle/faint micro-calcifications] and full-field digital
mammography improving mammographic sensitivity by about 5

%. The final major advancements in breast imaging became
prevalent in the early 2000's, with the improvement of the

computer based, highly-sophisticated breast MRI (Magnetic
Resonance Imaging) technology.

The new breast MRI creates an elliptical, homogenous

field of view, allowing the radiologist to see full
coverage of both breasts, chest wall and axillae in a

single scan, without any compromise in image contrast or

resolution. Revolutionary imaging technology developed
recently by Dr. Harms creates an exceptionally

high-quality MR image which allows breast MR to surpass

breast mammography in detection of early breast cancer.
Dedicated breast MRI systems are ideal for a wide

range of indications in breast disease management
including characterizing breast lesions, detecting occult

cancer, determining the extent of cancer, monitoring
cancer therapy, evaluating patients with positive surgical

margins for residual cancer, excluding the existence of
cancer in high-risk women, evaluating implant integrity,

and detecting cancer in women with breast augmentation.

2

Statement of Need
Today's woman is more aware of her health care needs.

The need for better care has become a focus of attention

in the media and publications targeting women. It is in
this current climate that interest has focused on breast

MRI as an important compliment to mammography. Although

some controversy exists among the experts regarding the
cost-to-benefit ratio of MRI, many recognize MRI as the

next generation in diagnosing breast cancer.

•

Statement of Purpose

This study is intended to determine the feasibility
of establishing a high-quality, frc■ocstaa.dsan^, dedicated

breast MR imaging center in the Redlands region.
Methods and Procedures
This study will address the industry dynamics,
potential market, and financial sustainability of
developing and sustaining such a center through a thorough

process of data collection and analyss.s.
Much data was collected and analyzed in preparing

this feasibility study including informal patient

interviews, referring physician interviews, internet
sources, medical journal literature review, U.S. Census

statistics, competitor sources, and vendor research.

3

Scope and UmkaHons

The scope of this study is limited to assessing the
feasibility of establishing a free-standing, dedicated MRI

center in the Redlands region. It does not address the

detailed level of analysis necessary to operationalize
t
this project such as such as architectural design,
!
structural parameters, radiology suite contractor
selection and construction, engineering, coordination of
I

acoustic and vibration analysis, radiation and magnetic

shielding, and special air conditioning needs. In

addition, more detailed sizing of the suite rooms,

■

selection of equipment manufacturer and model, and dhird

party contract negotiations will need to be explored.
.
Summary

i
[

•

This chapter intended to provide a brief history of

breast imaging advancements, an understanding of why it
may be advantageous to entertain a dedicated breast -j-MRI
I
center as a business venture, and a high-level orientation

to the content of this study.

4
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CHAPTER TWO

PRODUCT/SERVICE ANALYSIS
Scope of Services

This state-of-the-art breast MR imaging center will
be a special place of service that clients will be proud
of, and will provide an innovative niche in the health

care marketplace. It will combine cutting edge technology

with old fashion values.

The hours of operation will be 7 AM to 7 PM during 4
out of 5 weekdays, and 7 AM to 9 PM on Thursdays. In
today's busy and fast-paced lifestyle, it is often

difficult for patients to visit a health care facility

during the more typical business hours of 8 AM to 5 PM.

These few extra hours are strategically positioned to
improve satisfaction for patients and referring
physicians, thus encouraging future referrals.

The breast MRI center will be located near the

"

downtown Redlands community, in close proximity to two
major medical centers, and accessible to a major
thoroughfare. As physician's offices are typically located

in close proximity to hospitals, this site will be
centrally located to a strong referring physician base.

On-site parking will- complement the facility.

5

The Space and Physical Structure

The 1,300 square foot breast MRI Suite includes a
handicapped-accessible, MRI unit room, waiting room,
reception desks, dressing rooms, toilets, clean/soiled
utility rooms, storage, and a radiologist reading room.

The recommendations put forth by the AJR in June of
2002 is that MRI facilities be zoned, as a way of insuring

patient and staff safety. The first space that the

visitors enter in the MRI suite, i.e., the waiting and
reception areas is designated as Zone 1. The next zone,

Zone 2, is the connector between the publicly accessible,
uncontrolled Zone 1 and the strictly controlled Zones III
and IV, which in this facility will include the patient

dressing rooms and the gowned waiting room. The control
room and the room containing the electronic equipment for
the scanner are located in Zone 3 and designated as the
area in which uncontrolled access by unscreened non-MR

personnel and/or ferromagnetic objects and equipment can

result in serious injury or death. The most secure zone,
Zone 4, is the MR scanner room which is only accessible

from the control room.

.

Following these recommendations, the patient waiting
room will be near the MR facility entry, abutting the
reception area, and will have an easily accessible toilet

6

room. The MRI unit will be located toward the back, so
that traffic flowing through the department is kept to

f

minimum. Two dressing rooms and r gowned waiting room will
be located in proximity to the procedure room and rn
additional toilet room will be accessible from both the
dressing room and the gowned waiting room.
As to personnel flow, the work configuration is
designed in such r wry rs to separate staff and patient

traffic. The radiologist reading room is large enough for

a few clinical staff to collaborate, but small enough for
acoustic and visual privacy. A consultation room will be

located next to the radiologist reading area to avoid
disturbing private reading area. A separate medical
directory office should be centralized, with easy access

to the procedure room, radiologist reading room, rs well

as the reception area.
In regards to Information flow, several terminals
will be strategically located to provide for electronic

acquisition and distribution of data. In addition, the

system will support remote access, allowing for
out-of-office reading and consultations.
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Technical Specifications and Special Needs
The MRI equipment specifications and performance

shall meet all state and federal requirements. The breast
MR unit footprint needs a minimum of 550 square feet. It

weighs approximately 8,500 pounds, and it is best if
placed on the ground floor with no basement so that one
dimension of the magnetic field is directed into the

earth. The control room will be about 125 square feet. The
room will be shielded in accordance with regulatory

requirements as well.
Equipment Requirements and Selection

Several MRI systems were analyzed during the
equipment selection process, including Aurora, Seimans,
GE, and Toshiba. In the end, Aurora was the clear choice

in breast MRI systems. The Aurora 1.5T Dedicated Breast

MRI System is the only FDA approved, dedicated, and
integrated MRI system designed specifically for breast
imaging. With an exclusive precision gradient coil design,

the Aurora System provides an elliptical "sweet spot" that
images both breasts, chest wall, and axillae in a single

bilateral scan without compromise in image contrast or
resolution. The company offers an exclusive bilateral 3-D

8

technology that offers higher image quality and superior
dynamics, for superior breast disease diagnosis.
In addition, the Aurora system possesses a fully
integrated, biopsy system. The system also incorporates a

user-friendly computer-aided detection workstation
facilitating the physician in making the correct

diagnosis. This MR system has a table design that is
comfortable for the patient allowing her to enter the

imaging system feet-first, improving compliance and
decreasing anxiety for claustrophobic patients.

Policies and Procedures

Establishing policies and procedures related to
quality, patient education, infection control, and safety

is to be implemented in accordance to the American College
of Radiology.
Developmental Plan
It is estimated that this project will take

approximately 17 months to complete. Much of this time
will be spent in facility planning and construction, as

this center will be a new freestanding facility. The table
below details the major tasks and respective time
allocations .

•
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Table 1. Work Task Timeline
Function

Date Range

•

Project financing

4/1/07 - 4/30/07

Finalizing equipment purchase

5/30/07

Facility Design and Construction

5/1/07 - 4/30/08

MR Installation and Calibration

5/1/08 - 5/30/08

Staffing Plan

2/1/08 - 5/30/08

Customer Service Training

6/1/08 - 6/30/08

Management Service Contracts

1/2/08 - 3/30/08

State Licensing

1/2/08 - 4/30/08

Marketing and Communication Plan

3/1/08 - 7/01/08

Final Application Training

7/1/08 - 7/30/08

Patient Scheduling

7/1/08 - 7/30/08

Grand Opening of Imaging Center

8/1/08

Summary
This chapter attempted to define the breast imaging

center concept, provide an orientation to the general

constructs of the center, and propose a timeline to

completion.
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CHAPTER THREE
INDUSTRY ANALYSIS

Industry Demographics and Competitor Analysis

The services of the proposed breast MR imaging center
are unique to the region. Currently, there are only 22
dedicated breast MRI units in the entire country, and only
3 in California. Within a 60-mile radius, no dedicated

breast MRI facilities exist. The uniqueness of this
proposed medical facility is that it will provide a rare

state of-the-art technology, offering higher sensitivity
and specificity than mammography, without the added risk

of radiation from X-rays.

There is only one medical facility within the region
of interest that offers diagnostic only breast imaging on

a non-dedicated breast MRI system. This provider uses a
breast coil for the study, resulting in a more limited,

diagnostic detail than the proposed dedicated breast MRI

system. Schedule availability is limited at this facility,
with an average backlog of 2 weeks or greater. As this
facility serves the needs of all diagnostic patients, it

is difficult for them to cater to the unique needs of

women suffering from breast cancer.
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Differentiating Factors

The proposed breast MR imaging center will
differentiate its services from its competitors with a

focus in three key areas: competence, customer service,
and accessibility. It is the uncompromising goal and
expectation that women who will be undergoing imaging

breast evaluation at this proposed facility and their

referring physicians report exceptional satisfaction with
their experience.

Competence is paramount in complex imaging and begins
with acquisition of skilled technologists and a focus on

patient safety. The advantages of providing services to a

dedicated market are numerous. First, the technologist
performs a limited subset of imaging studies, thus

improving their skill set faster than a general
technologist and ensuring standardization and quality of

the study. Second, the center will be able to employ
appropriate technologists. A higher-quality diagnostic

breast study will be obtained when the patient is relaxed
and can cooperate with the instructions of the procedure.

For female patients (which comprise greater than 99.5 % of
patient's undergoing breast imaging evaluation), it is

essential that female technologists, nurses, or assistants

be involved in patient positioning and testing. Third,

12

patient safety can be better monitored in an intimate

setting with fewer personnel interacting with the client.
An example of this strict patient safety focus is the MRI
Safety Screening Questionnaire located in Appendices A and

B. This interaction with the patient prior to screening
ensures the client that their safety is important and

limits potential error on the practitioner's side.
Patient-focused customer service initiatives will aim

to educate the patient prior to their imaging appointment,
create an estheti^l^ attractive and relaxing atmosphere

rt the center, develop r caring culture with friendly and

competent personnel, and provide continued support for the
patient and family, including information resources,

exercise options, therapy programs, and support groups. An
example of patient education can be found in Appendix C.

Physician-focused customer service initiatives

include pre-printed prescription pads with driving

directions and a map included on the back of each
prescription, electronic access to results through f

secure conneccc.o^o same-day interpretation standards, and
direct communication access with the center's
radiologists. These initiatives speed the throughput

process so that detection-to-diagnosis-to start of therapy

can be achieved within as short

13

f

time frame as possible.

Accessibility for both customers will include a wider
range of facility hours, convenient parking, and easy
access to clinicians providing services.

Summary

■

'

It is evident that there is little competition in the
regional marketplace for dedicated breast MRI services.

Based on this information, and the Center's ability to
differentiate itself from the minimal competition, it is

likely that the Center will be able to establish itself in

the Redlands area.
This chapter attempts to provide an overview of the

breast imaging industry at large and locally, as well as
highlight important factors necessary to compete in the
regional market.
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CHAPTER FOUR
MARKET ANALYSIS
Customer Profiles

The American Cancer Society recommends breast imaging
screening begin in women at the , age of 40. In cases where

the client has a strong family history of breast cancer
(i.e., a mother or sister with breast cancer), then

breast-imaging screening should start 10 years prior to
when the close relative was first diagnosed. For clients

with clinical symptoms, breast MRI imaging can be done at
any age.

It is well documented that location is an important

consideration in accessing health care services. Patients
will typically choose a health care provider for routine

needs based on perception of quality and payer association

respective to a defined location.
Market Demographics

'

The U.S. Census statistics, provided in detail in

Appendices- D and E, reports the female population of

Redlands as 34,000. The total population of men and women
age 40 and above is about 25,000 people. Females make up

about 53% of this population group, hence the total number
of females age 40 and above is estimated as 13,250.
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On average, the Redlands resident is more affluent
and better educated in comparison to other Californians.

The city boasts at high school graduate rate of 86.6%
verses a California state rate of 76.8%. In addition,

35.2% of residents have a Bachelor's degree or higher
versus 26.6% of Californians statewide. The median per

capita income for a Redlands resident is about $24,237
versus $22,711 throughout the state.

These statistics are important in light of the facts

that educated patients with financial means are most
likely to research and obtain the latest advancements in

health care technology and delivery.

The proposed breast MRI center is projecting 5

patients per day. As the Center operates 252 calendar days
per year, it will need to screen 1,260 patients annually

to meet its targets. This equates to 9.5% of the target

market.

•
Summary'

Based on this information, it is realistic to assume
that this Center will realize the projected volumes,

considering the general absence of competition in the

local market. This assumption is based on another primary

16

assumption; that the Center will be able to accept all

payer sources associated with the target clientele.
It will be essential to understand the payers in the

San Bernardino region, as they can be considered a

customer and their rates are variable by region. This will

ultimately affect the Center's financial success, and will
be discussed in detail in the following chapter.
This chapter attempts to provide an overview of the

market and its customers, as well as establish a

projection of realistic volume.
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CHAPTER FIVE
FINANCIAL ANALYSIS

Payer Analysis

The chart below depicts the payer mix for breast MRI
procedures performed at a local hospital.

BREAST MRI

B SELF
» HMO

B PPO
B MCARE
■ MCAL

B COMM
B BLX/BLSH

Chart 1. Breast Magnetic Resonance Imaging Payer Mix of
Local Hospital

As noted, 40% of payments come from governmental

sources (i.e. Medicare and MediCal), and 60% of payments

are from third party payers. While governmental payers
tend to pay on a fixed fee schedule, managed organizations

typically negotiate their rates. Therefore, it is
important to understand the payer's constructs prior to

pursuing contracts.
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Medicare
2007 CPT Code Changes for Breast MR Procedures.

Effective January 1 2007, CPT codes 76093 and 76094 were

deleted. New codes became effective. at that time. The new
codes are:
77058

MRI without followed by with contrast,
breast; unilateral

77059

MRI without followed by with contrast,

breast; bilateral
Medicare Part B - National Health Insurance Corporation

(NHIC) is the Medicare Part B insurance carrier for this
locale and they have the new CPT codes in their system:
For procedures performed in the freestanding facility

setting, the Medicare Part B 2007 reimbursement par-rates
for locale 99 which includes San Bernardino County are as
follows:

77058

global

77058

professional

77059

global

77059

professional

$832.50
$78.38

$1028.98
$78.38

In 2007, Medicare Part B will reimburse for 3D

reconstruction billed with CPT code 76377 at the rate of
$161.18 for the global payment.
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The CAD code (0159T) became effective on July 1,
2006, and while it is recognized by this Carrier as an

acceptable code, it is not on the 1st quarter 2007 fee
schedule, but will be accepted as a tracking mechanism.

Please note the 2007 professional component
reimbursements above were adjusted up by 5% to account for

the roll back of the reduction that was to have been a
result of the application of the Sustainable Growth
Formula to the professional component. Carriers are in the

process of re-calculating the fee schedules at this time.
At this time, breast MR procedures are not included

on the Capped Fees File which includes all medical imaging
procedures subject to the DRA reductions.
MR contrast agents will continue to be reimbursed at

ASP plus 6 percent in 2007.

Medi-Cal

Medi-Cal will cover breast MR procedures from the
same coverage policy as Medicare and reimburses from the

CPT codes as follows:

,

76093

$361.69

76094

$478.19

The payer reimburses for 3D reconstruction at the rate of
$170.54, effective 12/01/06. This payer will update for

20

the new codes "as soon as possible", but should be
monitored for denials.

Aetna/USHealthcare
This payer will accept the new CPT codes for breast
MR procedures, CPT 76377 for the 3D reconstruction and MR

contrast media reported with the HCPCS code that
corresponds to contrast used in the procedure. Aetna
considers breast MRI medically necessary for screening of

women considered to be at high genetic risk of breast
cancer because of a) confirmed presence of BRCA1 or BRCA2

mutation; or b) who meet criteria for genetic screening

for breast cancer as established in the Aetna medical

coverage policy.
California Wellpoint Health Network (Blue Cross)

This plan covers high-risk screening for women with

the BRAC1 and BRAC2 mutati—n, patients considered to be at

high familial risk for breast cancer (those with a family
history suggestive of hereditary breast cancer), those

patients for which mammography is limited by factors such

as those with dense or distorted breasts, and for
screening the contralateral breast in patients who have
breast cancer. There is no reference to CAD in this

policy, and in discussions with the payer, it was
discovered that the payment for CAD is bundled into the

21

procedure reimbursement. The code for 3D reconstruction is

covered as an add-on and separately payable with the
limits of the patient's benefits. The plan does have the .

new CPT codes in its coverage policy.
California Blue Shield

1

California Blue Shield also will cover high-risk

screening for women with the BRAC1 and BRAC2 mutation and
patients considered to be at high familial risk for breast

cancer. They also cover 3D reconstruction, if performed as

a separate service and not simply an automatically
generated add-on.

Cigna

Cigna has a policy the lists the CPT codes 76094 for

breast MR and 76377 for 3D reconstruction procedures, but

has stated they will update their system to accept the new
codes effective January 1st 2007. This payer also accepts

product specific HCPCS code for MR contrast agents. This
payer will reimburse for screening of women considered to

be at high genetic risk of breast cancer.
HealthNet of California
This regional payer has an established policy for

breast MR For screening of women considered to be at high
genetic risk of breast cancer because of any of the
following: Confirmed presence of BRCA1 or BRCA2 mutation;
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or patients who meet criteria for genetic screening for
breast cancer as outlined in BRCA testing policy and

Prophylactic Mastectomy Policy (Pb^lP) . HealthNet policy
lists the CPT codes 76093 and 76094 for the primary

procedure and 3D reconstruction, but will accept 77058 and

77059 effective January 1st.

PacifiCare of California
This managed care plan will cover high-risk screening
for women with the BRAC1 and BRAC2 mutation and.patients

considered to be at high familial risk for breast cancer
as well as 3D reconstruction. PacifiCare will be updating

its system to accept the new CPT codes for breast MR
procedures , and accepts 76377 for 3D reconstruction

procedures; CAD code 0159T is not separately payable with
this payer.
Rate Information for Third-party Payers

Private third-party payers establish Usual and

Customary Charge (UCC) Fee Schedules for covered
procedures. Usual and Customary Charges are how payers

reimburse for both the technical and professional
component of procedures; contrast agents will most often

be reimbursed at cost. Unlike fee schedules for
governmental payers such as Medicare, Medicaid and
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Tri-Star, private payers cannot be compelled to make

payment rate data public. Information on private payment

is obtained from the Practice Management Information
Corporation (PMIC^) which compiles payment data by payer,

by locale on an annual basis. UCC payments are the rate f

provider will receive if the procedure billed is not
covered under a contract between the facility and the

payer. The UCC data provided by PMIC will often be less,

or in some cases more, than a provider may be receiving
under the terms of a contract with a specific payer. UCC

rates should be thought of as benchmarks with private
payers.
For San Bernardino County, PMIC provided the

following range of reimbursement rates for those

thcrd-paoCy payers that have coverage policies and UCCs

established for breast MR:
Low

$799

High

$1156

Average

$991

The 3U reconstruction billed with CPT code 76377 is paid
an average global rate of $225 statewide. Reimbursement
rates will also vary in accordance to the particulars of

the contract between the plan and the purchaser, with
policies having f range of co-pays and medical necessity
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and prior authorization requirements. These 2007
reimbursement rates are based on 2006 historical data as
compiled by PMIC.

Reimbursement for Magnetic Resonance
Contrast Media

While not all third-party payers will reimburse for
MR contrast it is important to report the use of these
agents to show utilization. Medicare does not reimburse

for MR contrast in the-freestanding facility setting

except in certain instances of high-dose administration.
When reimbursement is made for high-dose MR contrast, it
will be based on either 106% of Average Sales Price (ASP)

or invoice. The Medicare Part B Carrier may request a copy
of the invoice to determine cost and payment. Private

insurance plans will reimburse contrast agents in a number
if ways: flat rate, invoice or incorporate reimbursement
for contrast into the procedure payment.

Net Revenue Analysis

Based on this detailed analysis of payers, as
assumption was made that the Center's average net revenue

per case will be $1,089.79, and the annual net revenue
will be $1,373,135, assuming 1,260 cases per year.
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Table 2. Net Revenue Assumptions

NET REVENUE:

Exams/Day

Breast MRI Scans

Exams/Yr

Exams
1st Yr

1,260

5

Average Net Revenue per Patient

$

Total Annual Net Revenue

$ 1,373,135

* Estimate first Year Net
Revenue

$

420

1,089.79

457,712

Start-up Capital Requirements

Equipment and Construction Costs are a significant

consideration in determining the feasibility of this
project. These dollars will be invested at start-up and

depreciation of these expenses will be 5 years for
equipment and 20 years for facility construction.

Construction costs were based on estimates from a local
architect who specializes in medical facility
construction . The detailed costs are contained in Table 3

below.
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Table 3. Equipment and Construction Costs
Total Unit
Cost

Unit Cost

Units

Equipment:

Aurora Breast MRI

1

$ 1,345,000 $ 1,345,000

Vaccum Assisted Breast Biopsy

1

$

45,000 $

Total Equipment Costs

Construction & Soft Goods:

45,000

$ 1,390,000

Sq.Ft.

Total Cost

Cost/Sq.Ft.

Permits (included below)

$

Construction

1300

$

Total Construction Expense

-

600 $

780,000

$

780,000

Operating Expense Requirements
General operating costs are another significant

consideration in assessing the feasibility of this Center.
The risk on these variable expenses are much less than the
fixed expenses noted earlier, and will be volume

dependant.
To summarize, it is estimated that the cost of

operating the center will be $954,642 annually, assuming

1,260 cases in the same time frame. Table 4 details these
expenses.
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Table 4. General -Operating Costs
EXPENSES:

Paid Fte

Annual

Per/Unit

Wages - technologist

1.25

$ 29.08 $

67,502

Wages - Clerical

1.00

$ 13.72 $

25,478

$

31,613

Benefits
Other Expenses

$

8.09 $

10,193

Medical Supplies/scan

$ 61.50 $

77,490

Service Maintenance

$ 139,000

Depreciation

$ 316,973

Sub-Total Direct Expense

$ 668,250

Indirect Expense

$ 286,393

Total Expense

$ 954,642

Contribution Analysis

The five-year proforma documented in Appendix F
demonstrates the Center's sustainability. In year one, the

Center will experience a positive contribution of $62,877
and a total projected contribution of five years of
$1,962,188. This speaks to the strength of the Center's
operations, and is assuming a consistent reimbursement

rate per case over the next five years.
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Breakeven Analysis
In analyzing the Center's projected revenue and
estimated expenses, the Center would break even in 41
months, or 3.2 years as referenced in Appendix G.

Summary

Upon full review of the financial analysis, this
project demonstrates positive financial potential from
operations' each year and sustainability long term,

assuming .favorable contracts with third-party payers.
This chapter attempts to analyze the payer

environment that will affect revenues, document revenue

and expense assumptions, and project the financial

sustainability of the Center.
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APPENDIX A
MAGNETIC RESONANCE IMAGING SAFETY

SCREENING QUESTIONNAIRE
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Please indicate if you have any of the following:
Aneurysm clip(s)
'
Cardiac Pacemaker
Implanted cardioverter defibrillator(ICD)
Electronic implant or device
Magnetically-activated implant or device
Neurostimulation system
Spinal Cord Stimulator
Internal electrocodes or wires
Bone growth/bone fusion stimulator
Cochlear, otology, or other ear implant
Insulin or other infusion pumps
Implanted drug infusion device
Any type of prosthesis (eye, penile, etc)
Heart valve prosthesis
Eyelid spring or wire
Artificial or prosthetic limb
Metallic stent, filter or coil
Shunt (spinal or intraventricular)
Vascular access port and/or catheter
Radiation seeds or implants
Medication patch (Nicotine, Nitroglycerine)
Any metallic fragment or foreign body
Wire mesh implant
Tissue expander (e.g. breast)
Surgical staples, clips, or metallic sutures
Joint replacement (hip, knee, etc.)
Bone/joint pin, screw, nail, wire, plate, etc.
IUD, diaphragm, or pessary
Dentures or . partial plates
'
Tattoo or permanent make-up
Body piercing jewelry
Hearing aid
(Remove before entering MR system room)
Other Implants
Breathing problem or motion disorder
Claustrophobia

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No

□ Yes
□ Yes
□ Yes

□ No
□ No
□ No

□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□

Please mark on the figure(S) below
for the location of any implant or
metal inside or on your body.

I attest that the above information is correct to the best of my knowledge. I read and understand the
contents of this form and had the opportunity to ask questions regarding the information . on this form
and regarding the MR procedure that I am about to undergo.
Signature of Person Completing the form

Form Information Reviewed by:

Date:

Print Name

/

/

Form Completed by: □ Patient

^Relative DNurse □ Translator IZMRI Tech □ Radiologist

APPENDIX B

PRE-BREAST IMAGING QUESTIONNAIRE

Pre-Breast imaging Questions:
1.

Please provide your name/date of birth/ address/ telephone:

2.

Do you have breast implants? (yes/no)

3.

Is this a follow-up to an abnormal mammogram? (yes/no)

4.

Do you have any breast problems such as a lump, pain or discharge? (yes/no and if
“yes”, describe:_________________________________________________ )

5.

Did you or your doctor feel a lump in your breasts? (yes/no, if “yes”, where?
________________ and how long has it been there?________________________ )

6.

Have you had breast cancer without the removal of your breast? (yes/no, if “yes” did
you have radiotherapy (yes/no) or chemotherapy (yes/no)?))

7.

Have you had previous breast surgery or biopsy? (yes/no, if “yes which side was it
done on (right/left/both), in what month and year when was it performed_____ ?, and
what was found____________________?)

8.

Has any blood relative has breast cancer? ( yes/no)

9.

What is your age?

1

10. Are you still having menstrual periods? (yes/no)

11. Are you taking hormone therapy (yes/no, if “yes”, what type:_______________ )
12. Are you pregnant or nursing? (yes/no)
13. Do you have breast tenderness or pain at any time during the month? (yes/no, if “yes”,
schedule mammogram when breasts are less tender.)
14. If you have pain, is it in one spot? (yes/no)
15. Have you had a mammogram before? (yes/no, if “yes”, where was it done
________ and how long ago__________?)
16. Information on your primary physician or health care provider
(name/address/telephone):
17. When was the last time you saw your health care provider?
18. Do you have written referral (prescription) for this mammogram (yes/no, if “yes”,
please provide referral form)
19. Does your healthcare provide know that you are scheduling mammography? (yes/no, if
“no” the provider should be informed)

20. Is there any other information that would be helpful for us to know?

Source: imaginis.com/breasthealth/questionnaii-e.asp

APPENDIX C
PATIENT FACT CARD EXAMPLE

INTRODUCTION
MRI, magnetic resonance imaging, is a diagnostic procedure to view areas of the body without
using X-rays, Magnetic fields and radio waves are used to detect the ■ size and location of '
tumors, using a large, donut-shaped magnet. Breast MRI is used after a mammogram if more
detail is necessary because the doctor suspects there may be disease that ■the mammogram
cannot detect. You cannot have a breast MRI if you have a breast tissue expander or cardiac
pacemaker.
PREPARATION
• If you have a condition that makes it difficult for you to lie still in an enclosed area
(claustrophobia), or if lying. on your stomach with your arms stretched out above your
head for 30 to 60 minutes without moving is difficult, tell your doctor before the breast
MRI so that .medication can be prescribed to ■ help ease any discomfort you may have.

•

No other preparation is required. You may take medication(s) as usual.

TIME
The examination takes up to 40 minutes for both breasts.
PROCEDURE
• You will need to take off your jewelry, bra, and other clothing items that contain metal,
such as zippers or metal buttons.
• You will be able to store your belongings in a locker provided for you.
• Do not take any watches or any card with a magnetic strip. (such as a credit card) into
the MRI machine, as they may not work once exposed to the magnetic field.
• Before your breast MRI, the procedure will be explained to you, and any questions you
have will be answered.
• An intravenous line .(IV) will be placed in a vein to give you- an injection of a contrast
medium called gadolinium-DTPA. The contrast makes it possible to see any
abnormality in the breast. The IV will be removed at the end of your procedure.
• You will be asked to lie on your stomach on the MRI table. Once you are positioned, it
is extremely important that you do not move during the examination. Your breast will
be placed into two holes in the - table and - will be immobilized by compression paddles.
• You may request earphones so that you can listen to music or earplugs to make you
more comfortable and to reduce the clicking sound you will hear from the MRI
machine.
• You will be able to talk with the MRI technologist at any time during the examination. . If
you become uncomfortable in the MRI machine, tell the technologist.

AFTER THE PROCEDURE
• The site where the contrast medium was injected will be covered with an adhesive
bandage (Band Aid).
.
• A report of the scan will be sent to your doctor within a few days after your test.
Copyright 1999 Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 1
10021. Revised 2001
.

APPENDIX D

UNITED STATES CENSUS STATISTICS QUICK FACTS
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Redlands

People Quick Facts

Population, 2003 estimate
Population, percent change, April 1, 2000 to July 1, 2003
Population, 2000
Persons 65 years old and over, percent, 2000
Female persons, percent, 2000
High school graduates, percent of persons age 25+, 2000
Bachelor's degree or higher, pct of persons age 25+, 2000
Mean travel time to .work (minutes), workers age 16+, 2000

Housing units, 2000
Homeownership rate, 2000
Median value of owner-occupied housing units, 2000
Households, 2000
Persons per household, 2000
Median household income, 1999
Per capita money income, 1999
Persons below poverty, percent, 1999
Business QuickFacts

Wholesale trade sales, 1997 ($1000)
Retail sales, 1997 ($1000)
Retail sales per capita, 1997
Accommodation and foodservices sales, 1997 ($1000)
Total number of .firms, 1997
Minority-owned firms, percent of total, 1997
Women-owned firms, percent of total, 1997
Geography QuickFacts

Land area, 2000 (square miles)
Persons per square mile, 2000
FIPS Code

67,859
6.70%
63,591
12.60%
52.80%
86.60%
35.20%
23.5

California

'

35,484,453
4.80%
33,871,648
10.60%
50.20%
76.80%
26.60%
27.7

24,790
60.40%
$159,300

12,214,549
56.90%
$211,500

23,593
2.61
$48,155
$24,237
10.50%
Redlands
161,216
560,804
$8,390
59,116
4,790
18.00%
21.60%
Redlands
35
1,793.10
59962

11,502,870
2.87
$47,493
$22,711
14.20%

California
548,864,451
263,118,346
$8,167
42,312,641

2,565,734
28.80%
27.30%

California
155,959
217.2
6

Source U.S. Census Bureau: State and County QuickFacts. Data derived from Population Estimates, 2000
Census of Population and Housing, 1990 Census of Population and Housing, Small Area Income and Poverty
Estimates, County Business Patterns, 1997 Economic Census, Minority- and Women-Owned ' Business, Building
Permits, Consolidated Federal Funds Report, Census of Governments
Last Revised: Friday, 12-Jan-2007 16:03:49 EST

S'/'

APPENDIX E

UNITED STATES CENSUS STATISTICS, AGE DETAIL
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Subject

Total population

'

Number

Percent

63,591

100

30,024
33,567

47.2
52.8

3,964
4,684
. 5,014
5,231
4,554
8,254
9,498
9,043
3,026
2,342
3,742
2,980
1,259

6.2

SEX AND AGE

Male
Female

Under 5 years
5 to 9 years
10 to 14 years
15 to 19 years
20 to 24 years
25 to 34 years
35 to 44 years
45 to 54 years
55 to 59 years
60 to 64 years
65 to 74 years
75 to 84 years
85 ■ years and over

Median age (years)
18 years and over
Male
Female
21 years and over
62 years and over
65 years and over
Male
Female

7.4
7.9
8.2
7.2
13
14.9
14.2
4.8

3.7
5.9
4.7
2

35.1

(X)

46,940
21,620
25,320
43,614

73.8
34

9,375
7,981
3,084
4,897

14.7
12.6
4.8

39.8
68.6

7.7
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APPENDIX F

BREAST IMAGING CENTER INCOME STATEMENT
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YearO

Initial Capital Costs:
Equipment and Construction

$

Yearl

Year2

Year 3

Year 4

5.0% incr

5.0% incr

5.0% incr

5.0% incr

..Years
5.0% incr

2,170,000

Added Net Revenue:
Total Net Revenue for all

$

457,712

$

1,373,135

$

1,441,792

$

1,513,882

$

1,589,576

$

457,712

$

1,373,135

$

1,441,792

$

1,513,882

$

1,589,576

Additional Studies
Sub-Total Addtl Revenue

Expense:
Medical Supplies

$

41,531
25,830

Other Expenses
Service Maintenance

$

3,398

Indirect Expense

$

7,076

Depreciation

$

-

$

5.0% incr

5,0% incr

5.0% incr

Wages and Benefits

$

130,823

$

$

81,365

$
$

137,364
85,433

$

139,000

$

331,535

317,000

317,000

$

317,000

$

990,747

$

1,017,485

$

1,045,559

407,852

$

451,045

$

496,397

$

544,017

$

317,000

$

317,000

$

317,000

$

317,000

$

724,852

$

768,045

$

813,397

$

861,017

317,000

$
$

300,712

317,000

$

$

394,835

$

965,283

Net Contribution

$

62,877

$

Add back Depreciation

$

317,000

$

379,877

41

151,444
94,190
12,390

11,800
139,000

139,000

$

2,170,000

$
$

315,748

$

$

$

$
$

10,703
139,000

286,393

Net Cash per Year

$

144,232
89,704

$
$

11,238

$
$

Sub-Total Expenses

5.0% incr

5;0% incr
$

APPENDIX G

BREAKEVEN ANALYSIS
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Payback
6.25%

Year 0
Year 1
Year 2
Year 3
Year 4
Year 5

$

Cost
(-)
(2,170,000)

Expense
(-)

Net

$
$
$
$
$

457,712
1,373,135
1,441,792
1,513,882
1,589,576

$
$
$
$
$
$

(2,170,000)
379,877
724,852
768,045
813,397
861,017

(2,170,000) $

(2,828,909) $

6,376,097

$

1,377,188

$

(4,998,909) $

6,376,097

$

1,377,188

$
$
$
$
$

$

Income
(+)

T otals

(77,835)
(648,283)
(673,747)
(700,485)
(728,559)

Payback

3.42
41

43

years

months
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